|1.||Eyal, Sara: 1 article (11/2009)|
|2.||Madar, Igal: 1 article (11/2009)|
|3.||Zohar-Kontante, Hila: 1 article (11/2009)|
|4.||Weiss, Lola: 1 article (11/2009)|
|5.||Swed, Avi: 1 article (11/2009)|
|6.||Hoffman, Amnon: 1 article (11/2009)|
|7.||Karaliota, Alexandra: 1 article (03/2007)|
|8.||Thomadaki, Hellinida: 1 article (03/2007)|
|9.||Scorilas, Andreas: 1 article (03/2007)|
|10.||Litos, Charalambos: 1 article (03/2007)|
11/05/1985 - "Quantitative studies of MCF-7 cells (derived from human breast adenocarcinoma) and CV-1 cells (from normal African green monkey kidney epithelium), using the permeant cationic compound tetraphenylphosphonium (TPP), in conjunction with fluorescence microscopy using rhodamine 123 (Rh123), indicate that the mitochondrial and plasma membrane potentials affect both uptake and retention of these compounds. "
11/01/2009 - "Tetraphenylphosphonium (TPP), a phosphonium cation, is a promising means for tumor imaging. "
12/01/2004 - "Re: tetraphenylphosphonium as a novel molecular probe for imaging tumors."
04/01/2004 - "Tetraphenylphosphonium as a novel molecular probe for imaging tumors."
03/22/2007 - "We synthesized and studied the antitumor properties of the novel complex compound 2,5-dihydroxybenzoate molybdenum(VI) with tetraphenylphosphonium as counterion, which also acts as cancer cell growth inhibitor. "
04/15/1994 - "Mechanism of inhibition of FaDu hypopharyngeal carcinoma cell growth by tetraphenylphosphonium chloride."
11/01/1993 - "Tetraphenylphosphonium cation was readily identified and quantified (using methyltriphenylphosphonium cation as an internal standard) at subpicomole levels in crude lysate from < 4 x 10(3) FaDu human hypopharyngeal carcinoma cells. "
12/01/1989 - "Tetraphenylphosphonium cation (TPP) and other phosphonium cations selectively inhibited the growth in vitro of human pancreatic carcinoma-derived cells (PaCa-2) and Ehrlich Lettre Ascites cells (ELA) when compared with untransformed monkey kidney epithelial cells (CV-1). "
04/15/1994 - "Using 6 carcinoma-derived and 2 untransformed epithelial cell lines, tetraphenylphosphonium chloride (TPP) and other cationic aryl phosphonium salts (CAPS) demonstrated a growth inhibition pattern similar to that of cation rhodamine 123, suggesting that CAPS may inhibit mitochondrial function. "
01/01/1985 - "We also identified 3 other positively-charged lipophilic compounds, safranin 0, rhodamine 6G and tetraphenylphosphonium chloride (TPP+), which show selective toxicity toward carcinoma cells in vitro, while an uncharged lipophilic analog, rhodamine 116, does not. "
02/01/1979 - "Neuroblastoma-glioma hybrid cells (NG108-15) in suspension accumulate the permeant lipophilic cation [(3)H]tetraphenylphosphonium (TPP(+)) against a concentration gradient. "
01/01/1981 - "Demonstration of a muscarinic receptor-mediated cyclic GMP-dependent hyperpolarization of the membrane potential of mouse neuroblastoma cells using [3H]tetraphenylphosphonium."
07/01/1982 - "Vanadate hyperpolarizes mouse neuroblastoma-glioma hybrid NG108-15 by 20-30 mV. These changes in membrane potential (delta psi) are observed by monitoring the equilibrium distribution (intracellular/extracellular) of the lipophilic cation [3H]tetraphenylphosphonium (TTP+) and by directly measuring delta psi with intracellular microelectrodes. "
|2.||L-Lactate Dehydrogenase (Lactate Dehydrogenase)
|3.||1,2- diamino- 1,2- N,N'- carbonyl- 1,2- dideoxyglucose hydrate (CV-1)
|4.||Molecular Probes (Molecular Probe)
|6.||thymidine 5'-triphosphate (TTP)
|9.||Muscarinic Receptors (Muscarinic Acetylcholine Receptor)
|10.||Ouabain (G Strophanthin)